Home › Cholesterol › New York
Cholesterol clinical trials in New York
5 studies for Cholesterol are looking for participants at sites in New York.
Cities in New York
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Capital Cardiology Associates, Albany
- Sisters of Charity Hospital, Buffalo
- Trinity Medical WNY, PC, Buffalo
- and 5 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- University of Rochester, Rochester
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Astoria
- Research Site, Brooklyn
- Research Site, Brooklyn
- and 1 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Clinical Study Center, New York
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jul 17, 2026 · NCT06451770Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Icahn School of Med at Mt Sinai, New York
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated May 15, 2026 · NCT06597019From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.